GlassScriptPhysician profile
Jacob M Elam
NPI 1982163846
$2,957.57
in general payments reported to CMS, 2019-2025
18 companies · $1,422 in 2025
The $1,422 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.52 · 2023: $276 · 2024: $1,219 · 2025: $1,422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,504 · Travel and Lodging: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,504.17 |
| Travel and Lodging | $412.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $744.07 | 2024-2025 | Aquabeam System |
| Axonics, INC. | $458.54 | 2024 | Axonics |
| Medtronic, INC. | $446.16 | 2021-2025 | Interstim, Ligasure |
| Boston Scientific Corporation | $358.17 | 2023-2025 | Lithoclast, Lithovue, Ams 700 |
| Teleflex LLC | $213.78 | 2024-2025 | Barrigel |
| Ferring Pharmaceuticals INC. | $191.54 | 2024-2025 | Adstiladrin |
| Astellas Pharma US INC | $112.35 | 2023 | Xtandi |
| Coloplast Corp | $108.74 | 2024-2025 | |
| Tempus Ai, INC | $59.28 | 2025 | Xt Cdx |
| Sumitomo Pharma America, INC. | $54.15 | 2024-2025 | Orgovyx, Gemtesa |
| Laborie Medical Technologies Corp. | $51.31 | 2025 | |
| Merck Sharp & Dohme LLC | $34.13 | 2025 | Keytruda |
| Endo USA, INC. | $31.07 | 2025 | Xiaflex |
| Urogen Pharma, INC. | $26.11 | 2025 | |
| Tolmar, INC. | $23.71 | 2025 | Jatenzo, Eligard |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $15.60 | 2025 | Nanoknife |
| Conmed Corporation | $15.29 | 2025 | Airseal |
| Olympus America INC. | $13.57 | 2025 | Itind System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Elam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.